SLET 90% cheaper than CLET

A simplified version of a treatment pioneered in India to treat limbal stem cell deficiency (LSCD) has demonstrated comparable efficacy to its predecessor but at just 10% of the cost, according to a paper published in the British Journal of Ophthalmology.

 

You count your blessings

I have been in hospital. I have been counting my blessings, thankful to be in the hands of people who know what to do when things go wrong. I have been...

Central serous chorioretinopathy cases

Central serous chorioretinopathy (CSCR) is the fourth most common retinal disease¹. But unlike other common retinal diseases, CSCR commonly affects working-age...

Sun, slopes and the right eyewear

As cold weather begins to blanket the Southern Hemisphere, your patients are likely to be thinking about their winter sports activities. While some might...

Stars and their eyes… Steve Bate

Double-Paralympic champion Steve Bate was diagnosed with retinitis pigmentosa (RP) in 2011 and is officially blind, with about 10% of his vision remaining....

Business planning – a must have for every retail practice!

All practices should have a business plan, which for small or medium-sized practices could be as simple as a one-page document. A larger and more complex...

Bottom Banner Advert